Author: Sébastien Kandel

  |   Uncategorised

Imaging in support of Cancer Immunotherapy

The pharmaceutical company Roche and the Institute of Pharmacology and Structural Biology (IPBS) share the objective of developing cancer control strategies. While Roche is a major player in the development of immunotherapy strategies, IPBS aims to identify and characterize new therapeutic targets in the cancer field...

+
23 January
  |   Uncategorised

GeT: The Chromium device from 10x Genomics

During the last year, the GeT platform strengthened its technological offer in "single molecule" and "single cell" analysis. Indeed, 5 years ago, the platform was positioned among the first in "early access" on an automatic device for "Single Cell" preparation: the C1 of the Fluidigm...

+
23 January
  |   Uncategorised

Sophie Allart, Inserm Innovation Award 2017

The TRI Platform is honored with the presentation of the 2017 Inserm Innovation Award to Sophie Allart. Thanks to her great expertise in microscopy, Sophie Allart, biochemist and research engineer Inserm, has contributed to the discovery of the presence of the Zika virus inside the spermatozoid,...

+
15 December
  |   Uncategorised

Workshop Bioinfo – Biostat, 17th & 18th January 2018

This event organised in 2018, in addition to Genotoul, by the labex CIMI and by the Onconet Sudoe project, is the opportunity to continue a series of meetings and exchanges between bio-informatics, bio-statistics and biology teams. Exchanges concern methodological researches as well as data analysis...

+
17 November
  |   Uncategorised

Seminar « Long reads : dream or reality? »

The GeT platform organizes a seminar on Tuesday, November 28th at the INRA campus located in Castanet-Tolosan (Marc Ridet seminar room): Presentation of expertise and results obtained by research teams working on the lastest technologies available on GeT. Feel free to view the program and register for...

+
09 November
  |   Uncategorised

A probiotic bacteria produces a powerful painkiller.

The intestinal microbiota never ceases to amaze us. Metatoul participated in a study revealing the mode of action of a probiotic used in the symptomatic treatment of visceral pain. The bacterium produces a neurotransmitter (GABA) that, through its binding to a lipid, crosses the intestinal...

+
08 November